What are Corcept Therapeutics's profit margins?

Corcept Therapeutics (CORT) runs a 98.3% gross margin and a -1.1% operating margin, with a 6.2% net margin.

Where do Corcept Therapeutics's ratios come from?

Every ratio is computed from Corcept Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Corcept Therapeutics CORT Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	98.3%0.0pp	98.3%+0.1pp	98.2%-0.2pp	98.4%-0.1pp	98.4%0.0pp
Operating margin	-1.1%-7.0pp	5.9%-3.0pp	8.8%-5.4pp	14.2%-1.9pp	16.2%-4.1pp
Net margin	6.2%-6.9pp	13.1%-1.2pp	14.3%-4.3pp	18.7%-0.9pp	19.5%-1.4pp
Returns
Return on equity	7.2%-7.8pp	15%-1.7pp	16.7%-5.0pp	21.7%-0.1pp	21.8%-2.0pp
Return on invested capital	-1.4%-9.7pp	8.2%-4.6pp	12.8%-7.3pp	20.1%-1.8pp	21.9%-3.9pp
Efficiency
Asset turnover	0.9×0.0×	0.9×0.0×	0.9×0.0×	0.9×0.0×	0.9×0.0×
Liquidity
Current ratio	2.9×-0.1×	2.9×-0.2×	3.1×+0.1×	3.1×0.0×	3.1×-0.3×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$6.11+13.1%	$5.40+2.0%	$5.29+0.3%	$5.28-7.5%	$5.70-4.8%
Valuation
Market capitalization	$4.29B+17.1%	$3.66B-58.2%	$8.76B+7.6%	$8.14B-32.4%	$12.05B+128%
Price / earnings	90.6×+53.8×	36.7×-45.8×	82.5×+21.6×	60.9×-29.0×	89.9×+52.5×
Price / sales	5.6×+0.8×	4.8×-7.0×	11.8×+0.4×	11.4×-6.2×	17.6×+9.8×
Price / book	6.7×+1.1×	5.7×-8.2×	13.9×+1.1×	12.8×-4.8×	17.6×+9.9×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Corcept Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Corcept Therapeutics's profit margins?: Corcept Therapeutics (CORT) runs a 98.3% gross margin and a -1.1% operating margin, with a 6.2% net margin.
Where do Corcept Therapeutics's ratios come from?: Every ratio is computed from Corcept Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.